Lyxor MSCI World Health Care TR UCITS ETF - C-EUR
MULTI-UNITS LUXEMBOURG (SICAV domiciled in Luxembourg)
Key Information
Legal Documents
Performance
Analysis

Fund Profile

Category: SICAV

The Fund is an index-tracking UCITS passively managed. The investment objective of the Fund is to track both the upward and downward evolution of the MSCI WORLD HEALTH CARE Net Total Return Index (net dividends reinvested) ("Benchmark Index"), denominated in US Dollars, representative of healthcare companies from the Developed World markets, while minimizing the volatility of the difference between the return of the Fund and the return of the Benchmark Index (the “Tracking Error”). The anticipated level of tracking error in normal market conditions is indicated in the prospectus. Additional information about the Benchmark Index can be found at https://www.msci.com/. The Benchmark Index is a net total return index. A net total return index calculates the performance of the index constituents on the basis that any dividends or distributions are included in the index returns after withholding tax retention. The Fund seeks to achieve its objective via indirect replication by entering into an over-the-counter swap contract (financial derivative instrument, the “FDI”).The Fund may also invest in a diversified portfolio of international equities, whose performance will be exchanged against the performance of the benchmark Index via the FDI. Updated composition of the Fund holdings is available on www.lyxoretf.com. In addition, the indicative net asset value is published on the Reuters and Bloomberg pages of the Fund, and might also be mentioned on the websites of the stock exchanges where the Fund is listed. The share currency is the Euro (EUR). Invested financial instruments: FDI, international equities Dividend policy: the Fund's amounts available for distribution (if any) shall not be distributed to Shareholders, but reinvested. Net Asset Value: is calculated daily provided that the relevant stock exchanges are open for trading and orders can be covered. Redemptions: investors are able to redeem their shares on the primary market every valuation day before 18:30 Europe/Luxembourg and sell their shares on the secondary market at any time during trading hours on the Fund listing places.

Morningstar Rating
More information about the calculation of the Morningstar Ratings
Risk and reward profile
6
Lower Risk
Possible Lower
Returns
Higher Risk
Possible Higher
Returns
Key Information
Closing Price 26/05/2020339.69
Morningstar categorySector Equity Healthcare
CurrencyEUR
Distribution statusAccumulating
ISINLU0533033238
Inception Date19/08/2010
Minimum initial amount-
Exchange NameBORSA ITALIANA S.P.A.
TickerHLTW
Fees And Charges
Custody feeNone
Ongoing charge0.30% of which none is paid to MeDirect
Fund management company
AddressLyxor International Asset Management S.A.S. 17, cours Valmy Puteaux 92800 France
Manager NameSébastien Foy
Manager Start Date19/08/2010
Websitewww.lyxor.com
Total Net Assets (mil)485.22 EUR (30/04/2020)
UCITSYes
Administrator-

Documents

Prospectus
en 08/05/2020
Annual Report
en 31/12/2019
Semi Annual Report
en 30/06/2019
Morningstar Report
27/05/2020

Performance

Historical returns are no guarantee for future performances. Investing in Financial markets and securities involves risk. Past performance is not a guarantee of future results. Investment losses may occur and investors could lose some or all of their investment in the Fund.
Entry fees, purchase charges, custody fees, exit fees, sale charges and taxes are not included in the calculation of past performance. Ongoing charges (including management fees, administrative fees and other costs) have been taken in to account, as they are already included in the price/NAV of the fund.
Annualised performance in EUR
PeriodAnnualised returnDate
1 year20.07%26/05/2020
3 years11.27%26/05/2020
5 years6.11%26/05/2020
Since launch15.08%26/05/2020
Cumulative performance in EUR
Performance
YTD 01/01/20202.80
1 month0.70
3 months2.01
6 months4.42
Quarterly Returns
Q 1Q 2Q 3Q 4
2020-9.26%---
201911.12%0.02%3.42%10.59%
2018-3.87%8.74%11.43%-9.16%
20176.83%-0.04%-1.59%0.21%
2016-11.47%7.42%-0.64%0.91%
Dividend
No Data Available

Asset Allocation
% Long% Short% Net Assets
Stock100.00%0.00%100.00%
Bond0.00%0.00%0.00%
Cash0.00%0.00%0.00%
Other0.00%0.00%0.00%
Return/Risk Analysis
Risk Measurement1 Year3 Years5 Years
Standard Deviation
17.7114.1614.02
Sharpe Ratio
0.800.660.43
Sortino Ratio
1.671.080.63
Positive Months8.0023.0035.00
Negative Months4.0013.0025.00
Worst Month-6.02-8.96-8.96
World Regions
Region%
United States67.55
Europe - ex Euro11.58
Eurozone7.19
Japan6.21
United Kingdom4.71
Australasia2.25
Middle East0.21
Canada0.19
Asia - Emerging0.10
Stock Sector Weighting
Sector% of Equity
Healthcare100.00
Classification of Morningstar Category
Ranking1 Year2 Years3 Years5 Years
Top 25%
Category above the average
Category below the average
Bottom 25%
Morningstar Style Box
Equity Style
Large
Size
Mid
Small
Value
Blend
Growth
Style
339.69
Closing Price
All key information and documents must be reviewed before being able to Invest.